Baseline and serial molecular profiling predicts outcomes with hypomethylating agents in myelodysplastic syndromes

Autor: Hunter, Anthony M., Komrokji, Rami S., Yun, Seongseok, Al Ali, Najla, Chan, Onyee, Song, Jinming, Hussaini, Mohammad, Talati, Chetasi, Sweet, Kendra L., Lancet, Jeffrey E., Padron, Eric, List, Alan F., Sallman, David A.
Zdroj: In Blood Advances 23 February 2021 5(4):1017-1028
Databáze: ScienceDirect